Почетна › Множен миелом › Калифорнија › Baldwin Park
Клинички испитувања за Множен миелом во Baldwin Park, CA
23 студии за Множен миелом бараат учесници на локации во и околу Baldwin Park (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Се регрутираФаза 1
- City of Hope National Medical Center /ID# 280273, Duarte · на 4 милји
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Се регрутираФаза 1/2
- City of Hope National Medical Center, Duarte · на 4 милји
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Се регрутираФаза 4
- City of Hope, Duarte · на 4 милји
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 3
- City of Hope Duarte, Duarte · на 4 милји
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Се регрутираФаза 2
- City of Hope Medical Center, Duarte · на 4 милји
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Се регрутираФаза 1
- Research Site, Duarte · на 4 милји
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 1/2
- City of Hope - Duarte, Duarte · на 4 милји
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Се регрутираФаза 3
- City of Hope Duarte, Duarte · на 4 милји
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Се регрутираФаза 3
- City of Hope National Medical Center, Duarte · на 4 милји
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 1/2
- Research Site, Duarte · на 4 милји
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Се регрутираФаза 1/2
- Research Site, Duarte · на 4 милји
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Се регрутираФаза 1/2
- City of Hope, Duarte · на 4 милји
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Се регрутираФаза 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · на 4 милји
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Се регрутираФаза 1
- City of Hope Comprehensive Cancer Center, Duarte · на 4 милји
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Се регрутира
- City of Hope, Duarte · на 4 милји
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 2
- City of Hope Medical Center, Duarte · на 4 милји
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Се регрутираФаза 1
- City of Hope Comprehensive Cancer Center, Duarte · на 4 милји
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- City of Hope Medical Center, Duarte · на 4 милји
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- City of Hope, Duarte · на 4 милји
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Испитувања за Множен миелом во други градови
- New York City, NY60 студии
- Boston, MA42 студии
- Atlanta, GA42 студии
- Houston, TX38 студии
- Durham, NC37 студии
- Nashville, TN32 студии
- Denver, CO27 студии
- Rochester, MN24 студии
- St. Louis, MO24 студии
- Columbus, OH24 студии
- Edison, NJ22 студии
- Chicago, IL22 студии
Други студии во Baldwin Park
- Рак на дојка44 студии
- Акутна миелоидна леукемија40 студии
- Колоректален карцином37 студии
- Рак на бели дробови со не-мали клетки36 студии
- Рак (сите типови)34 студии
- Рак на простата30 студии
- Метастатски карцином30 студии
- Миелодиспластични синдроми26 студии
- Карцином на јајниците25 студии
- Рак на бели дробови24 студии
- Рак на стомакот22 студии
- Акутна лимфобластна леукемија21 студија
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.